Co-Founder @AganithaAI | Transforming BioPharma R&D with Computational Biology/Chemistry and AI | Building multi-disciplinary teams | Author
Joined July 2022
- Tweets27
- Following225
- Followers31
- Likes130
Prasad Chodavarapu retweeted
📢 Join us at #PMWC25 to talk about AI in BioPharma R&D
Vikram Duvvoori (@VikramDu), CEO of Aganitha.ai, will be presenting case studies showing how #GenAl & in silico modeling are mining insights from deep science to accelerate #BioPharma R&D. See you there.
ALT Beyond the Hype: Al Case Studies Accelerating Biopharma R&D Speaker: Vikram Duvvoori CEO & Co-Founder Aganitha Al Feb 5, 11:00 am, Showcase Track SI Precision Medicine World Conference (PMWC - 2025) Dates: 5 - 7 February 2025 Venue: Santa Clara Convention Center Booth: #B722
Prasad Chodavarapu retweeted
Delighted to share results from our Molecular Dynamics (MD) simulations investigating why Siponimod, a FDA-approved drug for relapsing forms of Multiple Sclerosis, activates its GPCR target, S1PR1 but not S1PR2, an off-target from the same family.
🧵👇
biorxiv.org/content/10.1101/…
Prasad Chodavarapu retweeted
Excited to announce Aganitha’s collaboration with @ccmb_csir to apply Generative AI solutions for designing novel therapeutics and research antibodies addressing needs in multiple disease areas.
More details at aganitha.ai/company/news-and…
Prasad Chodavarapu retweeted
Listening to Prof. George Church's keynote lecture on his seminal work on gene therapy and reversal of aging at the #IITBBiopharmaSummit2023
Prasad Chodavarapu retweeted
Great reporting from @Jared_Whitlock about biotechs shelving family-funded rare disease therapies
He tallies 26 rare-disease programs that were financially backed by patient groups and now canceled or paused in development:
endpts.com/families-raised-m…